Liangliang Shi

5PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Aug 26, 2022
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.

Jun Li, Gang Peng, Kuikui Zhu

|Jan 24, 2022
Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Xixi Liu, Bian Wu, Jing Huang

|Aug 28, 2020
Effects of Apatinib on the "Stemness" of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms.

Bin Yang, Yan Wang, Zhuoying Chen

|Aug 22, 2019
KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma.

Qiu-Ting Li, Yi-Ming Feng, Zun-Hui Ke

Pageof 1

Frequent Collaborators

2 joint publications

Kunyu Yang

1 joint publications

Zhuoying Chen

1 joint publications

Cheng Xu

1 joint publications

Si-Yang Wang